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utilization and HbA 1c levels (diabetic patients).  Results: Prev-
alence of major depression was reduced from 61% (T0) to 
28% (T4) in the intervention group and remained stable in 
care as usual (57% at T0 to 50% at T4). Compared to care as 
usual, significant improvement over time was observed in 
the intervention group with regard to depressive symptoms 
(F = 11.9; p = 0.001), perception of physical (F = 5.7; p = 0.018) 
and mental health (F = 3.9; p = 0.047) and quality of life (F = 
21.8; p  ! 0.001). Effects tended to be stronger in diabetes pa-
tients, in patients with baseline major depression and in pa-
tients with moderate INTERMED scores. Finally, hospital ad-
missions occurred less often in the intervention group, 
reaching statistical significance for the period between 6 
and 9 months of follow-up (p = 0.02).  Conclusions: The re-
sults suggest that a psychiatric intervention targeted for 
complex medical patients can improve health outcomes. 
 Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 Up to 30% of patients in the general hospital suffer 
from clinically relevant psychiatric comorbidities  [1, 2] . 
Such patients have high levels of functional impairment 
 [3, 4] , a longer hospital stay  [3, 5] , increased health care 
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 Abstract 
 Background: This study evaluated a multifaceted psychiat-
ric intervention targeted at the complex medically ill identi-
fied by means of the INTERMED, an instrument to assess case 
complexity.  Methods: Of 885 rheumatology inpatients and 
diabetes outpatients who were assessed for eligibility, 247 
were identified as complex (INTERMED score  1 20) and ran-
domized to the intervention (n = 125, 84 rheumatology and 
41 diabetes patients) or care as usual (n = 122, 78 rheumatol-
ogy and 44 diabetes patients). For the majority of the cases 
the multifaceted intervention consisted of an intervention 
conducted by a psychiatric liaison nurse and/or of referral to 
a liaison psychiatrist, followed by advice to the treating phy-
sician or organization of a multidisciplinary case conference. 
Baseline and follow-up at months 3, 6, 9 and 12 measured 
prevalence of major depression (Mini-International Neuro-
psychiatric Interview), depressive symptoms (Center for Epi-
demiological Studies Depression Rating Scale), physical and 
mental health (SF-36), quality of life (EuroQol), health care 
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utilization  [3, 6] , a diminished response to medical treat-
ments  [7, 8] and a reduced quality of life, independent of 
the severity of the physical illness  [9] .
 Consequently, psychiatric intervention studies have 
been conducted with the aim to improve health out-
come in patients with somatic and psychiatric comor-
bidities  [8, 10, 11] . While some of these studies demon-
strated a beneficial effect on psychosocial and medical 
outcomes  [12–14] and health care utilization  [15, 16] , 
others showed only minor or no effects  [17] . Authors re-
viewing these studies repeatedly criticized that they 
were not targeted at high risk patients, not conducted as 
randomized controlled trials and lacked adequate fol-
low-up  [18] .
 To target interventions is important in psychiatry and 
especially in consultation-liaison psychiatry, since most 
of the consultations are requested in emergency situa-
tions, late in the course of the hospitalization and for pa-
tients with overt behavioral disturbances  [19] . Such con-
sultations are rather oriented towards the needs of clini-
cians than of patients  [19] ; psychiatric interventions in 
the medically ill should therefore be based on indicators 
reflecting patient needs.
 Based on our previous work  [8, 20–29] , we hypothesize 
that not psychiatric diagnosis or psychopathology per se 
but the resulting case complexity is most important to 
explain variance between patients with regard to medical 
outcome and quality of life. Case complexity or ‘case mix’ 
refers to the characteristics which describe how patients 
with similar types and stages of disease vary in their 
health care needs and utilization. Case complexity is de-
termined by diagnosis but also by a variety of other pa-
rameters, such as chronicity, severity of illness, cognitive 
problems or depression  [20, 21, 29] . Over the last decade, 
an empirically based, valid and reliable instrument to as-
sess bio-psycho-social case complexity and resulting care 
needs, the INTERMED, has been developed  [22–24, 29] . 
The INTERMED has been shown to identify complex pa-
tients with a diminished response to medical treatments 
in various populations, such as patients admitted to in-
ternal medicine  [21] , patients with low back pain  [26] , di-
abetes  [27] , rheumatoid arthritis  [25] or cancer and mul-
tiple sclerosis  [29] .
 The    main    objective    of    this    study    was    to   evaluate  
the  benefits  of  targeting  a  psychiatric  intervention for 
the complex medically ill, identified by means of the 
 INTERMED.
 Methods 
 After approval by the ethics committee of the University Hos-
pital of Lausanne, the study started in November 2002, the last 
follow-up ended in April 2006. Screening for eligibility and inclu-
sion was performed by 3 psychiatric liaison nurses (F.B.H., D.B. 
and C.Z.); 2 nurses (F.B.H. and D.B.) provided the intervention 
and 1 (C.Z.), blinded to randomization, conducted follow-up as-
sessments.
 Patients 
 A total of 885 patients from 2 different populations were ap-
proached for inclusion in the study: (i) 229 patients with diabetes 
(25.9%) – the majority of whom classified as type 2 diabetes (n = 
156; 68.1%) – consulting the outpatient clinic of the Division of 
Endocrinology and Metabolism and (ii) 656 (74.1%) patients ad-
mitted to the inpatient unit of the Rheumatology Service of the 
University Hospital of Lausanne. Rheumatology inpatients were 
classified as having inflammatory diseases (such as chronic poly-
arthritis), degenerative diseases (such as arthrosis and chronic 
pain), age-related diseases (such as osteoporosis) and other dis-
eases (such as fibromyalgia). Diabetes patients were subdivided as 
having type 1, type 2 or another form of diabetes.
 Study Design and Randomization 
 Patients with the following exclusion criteria were not eligible: 
not speaking French, severe cognitive disturbances, terminal ill-
ness, planned placement in an institution, hospitalization for  ! 3 
days and suicidal risk. Eligible patients were included and, if iden-
tified as complex, randomized to the intervention or care as usu-
al by means of a computer-generated list.
 Assessments 
 Sociodemographic and medical characteristics: Age, sex, edu-
cational and professional status, as well as the above-mentioned 
medical diagnoses and strata of the rheumatology patients were 
recorded at baseline.
 INTERMED/case complexity: All eligible patients were 
screened for case complexity by means of the INTERMED (see 
 fig. 1 ). The INTERMED is an observer-rated instrument, which 
classifies information from a medical history-tacking into 4 do-
mains: biologic, psychological, social and health care. In each of 
the 4 domains 5 variables, related to ‘history’, ‘current state’ and 
‘prognosis’, are rated 0–3 according to a manual with clinical an-
chor points, resulting in a potential score range of 0–60 (a higher 
score indicates an increase in case complexity). The ratings are 
not specific but generic and apply to any somatic disease. A trained 
nurse can conduct and reliably rate the INTERMED interview 
within 15 min. Based on a cutoff score of  1 20 for identification of 
case complexity, the INTERMED was found to have good inter-
rater reliability (  = 0.85), test-retest reliability with a period of 1 
year between ratings (r = 0.75;   = 0.60) and internal consistency 
(estimated Cronbach’s   ranging between 0.78 and 0.94 in sev-
eral samples of patients with somatic illnesses)  [29] . The French 
version of the INTERMED was previously standardized by the 
first author (F.S.), who co-developed the INTERMED  [30] .
 Presence of current  major depression was assessed by means 
of the validated French version  [31] of the depression section of 
the Mini-International Neuropsychiatric Interview (MINI)  [32] , 
a standardized interview which can be conducted by a trained 
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layperson and assesses the presence of a research diagnosis of sev-
eral psychiatric disorders according to the criteria of the Diagnos-
tic and Statistical Manual of Mental Disorders (DSM-IVR)  [33] .
 Depressive symptoms were assessed by means of the Center for 
Epidemiological Studies Depression Rating Scale (CES-D)  [34] . 
The CES-D is a 20-item self-report scale developed to measure the 
severity of depressive symptoms. Subjects are asked how often they 
experienced each symptom during the last week; items are scored 
on a 4-point scale, ranging from 0 (rarely or never) to 3 (most of the 
time). The total CES-D score ranges from 0 to 60, a score  1 16 indi-
cates a clinically relevant depression  [34] . The overlaps with symp-
toms originating from a physical illness are limited; the CES-D has 
been proved to be a valid instrument in the physically ill  [35] , in-
cluding patients with rheumatoid arthritis  [36] and diabetes  [37] .
 Physical and mental health was measured with the validated 
French version  [38] of the SF-36  [39] . The SF-36 consists of 36 
items, organized into 8 scales (physical functioning, social func-
tioning, role limitations – physical, pain, mental health, role limi-
tation – emotional, vitality and general health)  [39] . The scales are 
recorded into standardized scores, subsequently used to construct 
2 summary scores: a Physical Health Component Score (PCS) and 
a Mental Health Component Score (MCS), based on the factors 
found by Hays and Stewart  [40] , with a scoring range between 0 
and 100 (100 = optimal functioning). The SF-36 has been proven 
to be a practical tool to measure self-assessed physical and mental 
functioning in the medically ill, including patients with rheuma-
toid arthritis and related disorders  [41] and diabetes  [42] .
 Health-related quality of life was assessed with the validated 
French version  [43] of the Visual Analogue Scale (0–100, a higher 
score indicating a higher quality of life) of the EuroQol. The Eu-
roQol has been used in many studies with the medically ill, in-
cluding patients with rheumatoid arthritis and related disorders 
 [44] and diabetes  [45] .
 Intervention 
 The control group received care as usual, which includes the 
possibility for the treating physician to request a psychiatric con-
sultation; both somatic services involved in this study have access 
to liaison psychiatry and regularly refer patients. The interven-
tion was designed as a multifaceted intervention in order to allow 
different approaches and to involve different health care profes-
sionals depending on the clinical situation of the patient. Three 
different interventions, single or combined, were proposed by a 
psychiatric liaison nurse: (i) supportive counseling focused on 
coping with disease and compliance with treatment, effectuated 
by the psychiatric liaison nurse; (ii) referral of the patient to a li-
aison psychiatrist, and (iii) advice to the treating physician or or-
ganization of a multidisciplinary case conference attended by the 
treating physicians and nurses, and a liaison psychiatrist.
 Follow-Up 
 Outcome was documented every 3 months during a 1-year fol-
low-up by the psychiatric research nurse (C.Z.), who was blinded 
to the intervention. Follow-up consisted of baseline measures (ex-
cept for the medical and sociodemographic characteristics and 
the INTERMED) and health care utilization, based on a method-
ology used in prior studies  [25–27] : patients are asked to docu-
ment in a booklet days of hospitalization, visits to a specialist or 
a general practitioner, emergency room visits and paramedical 
consultations covered by health insurance. The patients answered 
the questionnaires by mail; if they did not respond, the research 
nurse collected the information during a telephone interview. For 
diabetes patients, HbA 1c levels were recorded by chart review.
 Statistical Analyses 
 Effects of intervention were evaluated with regard to (a) prev-
alence of major depression (MINI); (b) depressive symptoms 
(CES-D); (c) physical health (PCS); (d) mental health (MCS), and 
(e) quality of life (QoL). We applied a repeated measurements 
analysis using the SPPS mixed model approach, since outcomes 
were assessed repeatedly during the follow-up at 3, 6, 9 and 12 
months after randomization. An advantage of this approach is 
that optimal use is made of the available data at the repeated as-

































 Fig. 1. The INTERMED scoring grid, 
copyright 1999 (Elsevier Science). For 
more information: www.intermedfounda-
tion.org  [30] . Examples from the INTER-
MED scoring manual: premorbid psychi-
atric dysfunction (history): 0 = no history 
of psychiatric dysfunction; 1 = a history of 
psychiatric dysfunction without effects on 
daily functioning; 2 = a history of psychi-
atric dysfunction with an impact on daily 
functioning; 3 = a history of at least 1 psy-
chiatric inpatient admission; x = unknown, 
no information available. 
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this analysis allows to evaluate differential change over time be-
tween treatment arms on the outcomes. Also, this analysis limits 
the number of comparisons, thereby reducing the chance of spu-
rious findings. To evaluate treatment effects, we developed 
mixed models for each of the 4 outcomes with continuous dis-
tributions (CES-D, PCS, MCS, QoL) consisting of treatment al-
location as a factor, the corresponding baseline variable and the 
timing of the assessment. The following preplanned subgroup 
analyses were conducted to further pin down the effects of the 
intervention: (1) rheumatology patients versus diabetes patients; 
(2) patients with versus without major depression at baseline, 
and (3) patients with INTERMED scores 20–30 versus  1 30. For 
these subgroup analyses, mixed models using the CES-D as out-
come were applied, and subgroup membership (i.e. rheumatol-
ogy or diabetes) and its interaction with treatment condition as 
covariates was added.
 Results 
 Of the 885 patients assessed for eligibility (see  fig. 2 ), 
184 (20.8%) met exclusion criteria, such as not speaking 
French (n = 43), severe cognitive disturbances (n = 27) or 
hospitalization for  ! 3 days (n = 28); 6.2% refused to 
 participate   (n   =   55).   Of   the   remaining   patients   (n   =  
701), 64.8% (n = 454) did not qualify as complex patients 
(INTERMED score  ! 20). The remaining 247 patients 
were randomized, 125 (84 rheumatology inpatients and 
41 diabetes outpatients) to the intervention and 122 to 
care as usual (78 rheumatology inpatients and 44 diabetes 
outpatients). With regard to sociodemographics (age, sex, 
educational and professional status) and baseline mea-
surements (including the above-mentioned strata of the 
rheumatology patients and the different types of diabe-
tes), the intervention and care as usual groups did not 
Intervention (n = 125)
RA: n = 84; DM: n = 41 
Usual care (n = 122)
RA: n = 78; DM: n = 44  
Assessed for eligibility (n = 885)
Reasons for exclusion: 
Language (n = 43) 
Cognitive problems (n = 27) 
Terminal illness (n = 9) 
Placement (n = 12) 
Hospitalization <3 days (n = 28) 
Suicidal risk (n = 4) 
Logistic problem (n = 6) 
Refusal (n = 55)
Randomized (n = 247; RA: n = 162; DM: n = 85)
Care as usual
(n = 120)

















Lost (n = 2)
No treatment
(n = 13) 
Intermed <21 (n = 454)
Treatment
(n = 107)
 Fig. 2. Patient flow chart. RA = Rheumatoid arthritis; DM = diabetes mellitus; Fu = follow-up. 
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differ at baseline. Based on the MINI, more than half of 
the sample (61% of the intervention group and 56% of the 
care as usual group) qualified for a diagnosis of major 
depression.
 In the intervention arm, most patients (n = 107) re-
ceived an intervention conducted by the psychiatric liai-
son nurse; the interventions, effectuated as single inter-
ventions or combined, consisted of ‘facilitating emotion-
al expression’ (73%), ‘practical advice’ (71%), ‘promoting 
life narrative’ (48%) and ‘psychoeducational interven-
tions’ (44%). For about half of the patients in the interven-
tion group (n = 76) also other types of intervention were 
proposed, such as referral to a liaison psychiatrist (n = 
36), psychiatric advice to the treating physician (n = 32) 
or interdisciplinary case conferences (n = 8). A minority 
of patients (n = 13) did not receive any treatment (due to 
a lack of indication for a psychosocial intervention or pa-
tient lacking motivation). The liaison nurses, who effec-
tuated the intervention, were supervised weekly by a se-
nior psychiatrist (F.S.) or an experienced psychiatric liai-
son nurse (Y.D.).
 Between 62 and 70% of the patients of the intervention 
arm and between 57 and 69% of the patients of the usual 
care arm provided complete follow-up data at the 4 time 
points (see  fig. 2 ). Patients with missing data did not dif-
fer from patients with complete data with regard to age, 
sex, educational and professional status, baseline quality 
of life and depression on each of the 4 follow-up assess-
ments.
 Effects of Intervention 
 In  figures 3–7 , comparisons between patients in the 
intervention arm and usual care arm on the main out-
comes are presented. Overall, the intervention was asso-
ciated with less depression and higher levels of quality of 
life during follow-up.
 Mixed model analyses of these data resulted in the fol-
lowing observations: controlling for baseline CES-D and 
timing of assessment, intervention is associated with 3.0 
(s.e. = 0.9) points less on CES-D (F = 11.0; p = 0.001). Con-
trolling for baseline PCS and timing of assessment, inter-
vention is associated with a 1.6 (s.e. = 0.7) higher score on 



























 Fig. 3. Effects on prevalence of major depression (MINI). 























 Fig. 4. Effects on depressive symptoms (CES-D). 
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PCS (F = 5.8; p = 0.02). Controlling for baseline MCS and 
timing of assessment, intervention is associated with a 
2.5 (s.e. = 1.0) higher score on MCS (F = 6.6; p = 0.01). 
Controlling for baseline QoL and timing of assessment, 
intervention is associated with a 7.8 (s.e. = 1.6) higher 
score on QoL (F = 23.7; p  ! 0.001).
 Health care utilization did not differ between the 
groups, except for percentage of hospitalized patients 
over the follow-up period, which differed in favor of the 
intervention, reaching significance at month 9 ( fig. 8 ). 
For only 15 patients in the intervention and 13 patients in 
the care as usual arm at least a baseline and 1 follow-up 
HbA 1c was documented; this did not allow a meaningful 
statistical analysis.
 Subgroup Analyses 
 Using mixed model analyses, the effects of interven-
tion on CES-D scores tended to be stronger in diabetes 
patients [effect size: 5.2 (s.e. = 1.5); p = 0.001] than in 
rheumatology patients [effect size: 1.7 (s.e. = 1.1); p = 
0.14]; this interaction effect was marginally significant
(p = 0.065). Larger effects were found in patients with a 
baseline major depression [effect size: 4.1 (s.e. = 1.2); p = 
0.001] than without [effect size: 1.6 (s.e. = 1.4); p = 0.26]; 
however, the interaction term was not significant (p = 
0.18). Finally, larger effects were also observed in patients 
with an INTERMED score 20–30 [effect size: 2.5 (s.e. = 
1.0); p = 0.01] than  1 30 [effect size: 1.2 (s.e. = 2.1); p = 
0.59]; this interaction term was not significant either
(p = 0.59).
 Discussion 
 Of the patients screened with the INTERMED, 35% 
qualified as complex (cutoff  1 20). This prevalence is in 
line with previous reports  [47] and confirms the utility of 
the INTERMED as a screening instrument for case com-
plexity, even in a selected population of patients of a ter-
tiary care center suffering from chronic conditions, 
known to be associated with an important psychiatric co-
morbidity  [48, 49] .


































 Fig. 5. Effects on physical health (PCS).  Fig. 6. Effects on mental health (MCS). 
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 The high prevalence of major depression in complex 
patients (more than half of the sample at baseline) under-
lines the already observed strong association between de-
pression and case complexity, which may influence each 
other  [50] . Other investigators found about half of these 
prevalence rates of depression in patients with diabetes 
and rheumatological disorders  [48, 49] ; however, these 
were overall prevalence rates, while the prevalence of ma-
jor depression in this study concerns a selected minority 
of complex patients. Despite the fact that the MINI is a 
validated instrument to provide a research diagnosis of 
major depression, we cannot exclude that a clinical inter-
view by a psychiatrist would have led to a lower preva-
lence rate of major depression due to positively screened 
patients with adjustment disorders, minor depression 
and subthreshold depressive disorders.
 The multifaceted psychiatric interventions described 
above were organized by psychiatric liaison nurses. Pa-
tients who needed further assessment or psychopharma-
cological treatment were referred to a liaison psychiatrist 
or advice, for example with regard to psychopharmaco-
logical treatment or general management, was provided 
to the treating physician. Since we had not anticipated 
such a high prevalence of depression, psychopharmaco-
logical treatment was not recorded; therefore we are not 
able to firmly identify the specific ‘beneficial elements’ of 
the intervention. It might be that psychopharmacological 
treatment was more frequently utilized in the interven-
tion group, due to referral to a liaison psychiatrist or ad-
vice given to treating physicians. Interdisciplinary case 
conferences were rarely organized, mainly due to the lack 
of time of the medical staff.
The intervention was effective with regard to different 
outcomes. Prevalence of major depression decreased in 
the intervention group; at 12 months of follow-up it was 
reduced from  1 50% at baseline to  ! 30%, while in care as 
usual it remained almost stable. Similarly, in the inter-
vention arm depressive symptoms consistently decreased 
over time, while in care as usual they remained stable or 
tended to increase. Prior studies on the treatment of de-
pressive symptoms in the medically ill did not always re-
sult in a significant effect, perhaps because many inter-
ventions were not targeted for specific subgroups of pa-
tients  [51, 52] .
 Perception of physical health improved in both groups, 
mainly within the first 3 months; however, this increase 
over time was consistently in favor of the intervention. 















































 Fig. 8. Effects on new hospitalizations. T3: p = 0.64; T6: p = 0.26; 
T9: p = 0.02; T12: p = 0.41. 
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Perception of mental health also improved over time, 
with significant improvement for the intervention group 
compared to care as usual, but this difference reached a 
peak at 3–6 months of follow-up. With regard to quality 
of life, a similar result was found, with a constant differ-
ence favoring the intervention arm over the whole follow-
up period of a year. Taken together, these results confirm 
that this targeted psychiatric intervention reduced emo-
tional distress and improved health perception and qual-
ity of life. These results are important in view of the fact 
that the INTERMED interview, conducted in both 
groups, may have a therapeutic effect by itself; in prior 
studies, patients were very positive about being inter-
viewed with the INTERMED  [27] , a finding which was 
specifically confirmed in a recent study  [53] .
 Medical outcome with regard to health care utilization 
did not differ between the groups, except for the percent-
age of patients who had to be hospitalized; fewer patients 
of the intervention group were hospitalized during each 
3-month period of the follow-up, reaching a significant 
difference between months 6 and 9.
 The benefits of the intervention may be due to more 
frequent and earlier detection and treatment of psycho-
social problems. A prior study with the INTERMED 
based on psychiatric liaison nurse interventions only re-
sulted in a significant effect on quality of life of a sub-
group of elderly patients; however, the interventions were 
not targeted and closer to hospital-based case manage-
ment than to a psychiatric intervention  [47] . The fact that 
the INTERMED can be considered as an instrument 
which is more inspired by ‘clinimetrics’ and ‘communi-
metrics’ than ‘psychometrics’ may also explain these ben-
efits  [54] . In addition, the INTERMED allows, in contrast 
to case management and disease management plans, not 
only to assess bio-psycho-social case complexity but also 
to direct individualized care  [55] . Ouwens et al.  [56] , who 
discussed 13 systematic reviews of integrated care pro-
grams for chronically ill patients, found that only 1 re-
view reported a significant positive effect on functional 
health status and only 3 reported a significant positive 
effect on hospital readmissions or length of stay.
 Subgroup    analyses    revealed    a    different    impact    of  
the intervention with regard to depressive symptoms, 
medical diagnosis, presence of major depression and 
 INTERMED scores. The more beneficial effect of the in-
tervention in diabetes patients may be due to their status 
as outpatients and a less important burden of disease but 
also to the stratum of ‘degenerative diseases’ of the rheu-
matology patients; in this stratum were included patients 
hospitalized for pain, often chronic pain and somatoform 
disorders, thus difficult to treat both from a physical and 
psychological point of view. Improvement of outcome in 
patients with a presence of major depression at baseline 
is not a spectacular finding, since improvement of major 
depression has most probably influenced the other out-
come variables. Patients with a high degree of case com-
plexity might have benefited less, since such patients are 
often in a chronic state with regard to their physical, psy-
chological and social situation, which is difficult to influ-
ence; a finding which is confirmed by prior studies with 
the INTERMED  [26] . However, these results are all based 
on subgroup analyses and should be considered as hy-
pothesis-generating only.
 Two randomized controlled trials have assessed the ef-
fectiveness of implementing psychiatric interventions on 
general medical wards by means of standard screening for 
psychiatric symptoms and subsequent treatment  [57, 58] . 
In the first study  [57] , no evidence for a reduction in length 
of hospital stay, hospital-based or post-discharge costs 
upon follow-up was found. In the second study  [58] , no 
evidence was found for an improvement of mental health 
status, quality of life or costs upon follow-up. The re-
sults of this study support the strategy to utilize the
INTERMED to screen and assess case complexity and to 
orient patient care. The INTERMED is already utilized on 
a routine basis in different clinical settings  [55] ; this study 
confirms these clinical experiences and adds evidence 
with regard to the validity of the INTERMED.
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